YMCC and YSN: An Opportunity for Scientific and Cultural Exchange
ACS Med Chem Lett
.
2023 Aug 29;14(9):1129-1130.
doi: 10.1021/acsmedchemlett.3c00337.
eCollection 2023 Sep 14.
Authors
Lori Ferrins
1
,
Margaret E Olson
2
,
Krupanandan Haranahalli
3
,
Melissa C Grenier-Davies
4
,
Matthew W Boudreau
5
,
Brieuc Matagne
6
,
Etienne J Donckele
7
,
Chiara Borsari
8
Affiliations
1
Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
2
College of Science, Health and Pharmacy, Roosevelt University, Schaumburg, Illinois 60173, United States.
3
Ginkgo Bioworks, Boston, Massachusetts 02210, United States.
4
GSK, Cambridge, Massachusetts 02140, United States.
5
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, United States.
6
EFMC & LD Organisation, B-1348 Louvain-la-Neuve, Belgium.
7
Monte Rosa Therapeutics, 4057Basel, Switzerland.
8
Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, Italy.
PMID:
37736173
PMCID:
PMC10510492
(available on
2024-09-14
)
DOI:
10.1021/acsmedchemlett.3c00337
No abstract available
Publication types
Editorial